Darego O. Maclayton, Pharm.D., BCPS
Reportable Conflicts of Interests: None
Disclosure of Financial Conflicts of Interest: None
Education:
Doctor of Pharmacy
Texas Southern University
College of Pharmacy and Health Sciences
Post Graduate or Residency Training:
ASHP Accredited Infectious Diseases Specialty Residency
Texas Tech University Health Sciences Center/
North Texas Veteran Health Care System
Dallas, TX
Infectious Diseases Fellows’ Core Curriculum
UT Southwestern Medical School (completed 39 hours)
Dallas, TX
ASHP Pharmacy Practice Residency
Baptist Memorial Health Care
Memphis, TN
Fellowship and Board Certifications:
Board Certified Pharmacotherapy Specialist by the Board of Pharmaceutical Specialties
Current Position or Practice Site:
Clinical Pharmacist Specialist
Michael E. DeBakey Veterans’ Affairs Medical Center
Houston, TX
Assistant Professor
Department of Pharmacy Practice
Texas Southern University
College of Pharmacy & Health Sciences
Houston, TX
Professional Memberships:
Houston Infectious Diseases Network
American Association of Colleges of Pharmacy
Society of infectious Diseases Pharmacists
American Society for Microbiology
American College of Clinical Pharmacy
American Society of Health System Pharmacists
Phi Lambda Sigma Pharmaceutical Fraternity
Kappa Psi Pharmaceutical Fraternity Inc
Student National Pharmacy Association
Publications:
Maclayton DO, Hall RG, Revankar SG, Amirkhan RH. Effects of Obesity on the Clinical Outcomes of Methicillin-Sensitive Staphylococcus aureus Bacteremia (submitted).
Maclayton DO and Eaton-Maxwell A. The Role of Rifaximin in the Treatment of Hepatic Encephalopathy. Annals of Pharmacotherapy February 2009.
Yeh R, Kuper K, Coyle E, Garey K, Ikwuagwu J, Maclayton DO, Mohr J, Musick W, Pass S, Rios E, Tam V. Significant Publications on Infectious Diseases Pharmacotherapy 2007. Am J Health-Syst Pharm. 2008;65: ):e72-e79.
Darego Maclayton, Pharm.D., BCPS Eaton-Maxwell A, Maclayton DO, Nguyen H. Current and Emerging Treatment Options for Postmenopausal Osteoporosis. Formulary 2008; 43:166-179.
Bain AM, Payne KD, Rahman, AP, Bedimo RJ, Maclayton DO, Rodriguez-Barradas MC, and Busti AJ. The Lipid-Lowering Efficacy of Switching within the Non-Nucleoside Reverse Trancriptase Inhibitors in HIV-infected patients. Am J Infect Dis 2008;4(2):147-151.
Nguyen ST, Eaton SA, Bain A, Payne K, Rahman A, Herrington J, Maclayton DO,
Rodriguez-Barradas M, Busti AJ. The lipid lowering efficacy and safety after a switch to an atazanavir/ritonavir based HAART in HIV-infected patients: a multi-center retrospective study. Pharmacotherapy 2008 Mar; 28(3):323-30.
Maclayton DO and Hall RG. Pharmacologic Treatment Options for Nosocomial Pneumonia Involving Methicillin-Resistant Staphylococcus aureus (MRSA) Ann Pharmacother 2007; 41:235-44.
Maclayton DO, Suda KJ, Coval KC, York CB, Garey KW. Case-Control Study of the
Relationship Between MRSA Bacteremia with a Vancomycin MIC of 2 µg/mL and Risk
Factors, Costs, and Outcomes in Inpatients Undergoing Hemodialysis. Clin Ther 2006; 28:1208-1216.
Presentations (National, State and Local):
Treatment Options for Nosocomial Pneumonia Involving Methicillin-resistant Staphylococcus aureus Bacteremia. Invited presentation at the 58th Texas Society of Health-System Pharmacists Annual Seminar, Galveston, Texas, April 2006.
Maclayton DO, Hall RG, Revankar SG, Amirkhan RH. The Effects of Obesity on the Clinical Outcomes of Methicillin-Sensitive Staphylococcus aureus Bacteremia. Presented by D. Maclayton at the Southwest Conference for Pharmacy Residents, Fellows and Preceptors (ALCALDE XIX), Austin, TX, April 2005.
Maclayton DO, Suda KJ, Coval KC, Gladney TJ, York CB, Garey KW . Case-Control Study of Hemodialysis Patients with Methicillin Resistant Staphylococcus aureus Bacteremia. Presented by D. Maclayton at the Southeastern Residency Conference (SERC), Athens, GA, May 2004.
Daptomycin as an Alternative Treatment for Methicillin Resistant Staphylococcus aureus Infections (ACPE#_508-000-04-005-L01) to system administrators, pharmacists and residents at Baptist Memorial Healthcare, Memphis, Tennessee, February 2004.
An Overview of Intra-Abdominal Infections to pharmacists, residents and students at Baptist Memorial Hospital, Memphis, Tennessee, February 2004.
Reducing Antimicrobial Resistance in the Intensive Care Units via Antimicrobial Cycling to pharmacists and residents at Baptist Memorial Hospital, Memphis, Tennessee, December 2003.
Intravenous Immunoglobulin-induced Renal Failure to pharmacists at Baptist Memorial Hospital, De Soto, Mississippi, October 2003.
Presented to pharmacists, residents and students at Baptist Memorial Hospital, Memphis, Tennessee, September 2003
(Last updated: 2/9/2009)
